Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
3.
Clin Exp Optom ; 106(8): 859-868, 2023 11.
Artículo en Inglés | MEDLINE | ID: mdl-37914536

RESUMEN

CLINICAL RELEVANCE: Optimisation of vision screening programmes can result the detection of refractive anomalies in a high proportion of school children. BACKGROUND: The Refractive Errors Among Children (REACH) programme aims to optimise outcomes of school-based vision screening in India by collaborating with hospitals and monitoring eye care throughout school attendance. METHODS: REACH delivers school vision screening using pocket vision screeners (cards presenting rows of seven 0.2 logMAR Sloan letters at a 3 m viewing distance) in five states across India. Children who fail screening are referred for detailed evaluation including refraction, those requiring cycloplegic refraction are referred to partner hospitals. Spectacles are dispensed as needed and compliance is assessed. All data are recorded electronically. RESULTS: Out of 2,240,805 children aged 5 to 18 (mean 11.5; SD ±3.3) years, 2,024,053 have undergone REACH screening in 10,309 schools predominantly in rural locations (78.7%) and government-funded (76%). Of those screened, 174,706 (8.6%) underwent detailed evaluation. A higher proportion of children in private or urban schools (11.8% and 10.4% respectively) were referred for detailed evaluation than those in government-funded or rural schools (5.9% and 7.2%, respectively; p < 0.001). The proportion referred for detailed evaluation differed by state (p < 0.001), from 4.0% in West Bengal to 14.4% in Kerala. CONCLUSION: The REACH programme screened a high proportion of school children, providing further care and follow-up to optimise visual outcomes.


Asunto(s)
Errores de Refracción , Selección Visual , Humanos , Niño , Agudeza Visual , Errores de Refracción/diagnóstico , Errores de Refracción/epidemiología , Errores de Refracción/terapia , Refracción Ocular , India/epidemiología , Prevalencia
4.
Pediatr Dermatol ; 38(3): 575-579, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-33611836

RESUMEN

BACKGROUND/OBJECTIVES: Pulsed dye laser (PDL) is the gold standard for treating port-wine birthmarks (PWBs), but no consensus exists regarding anesthetic techniques when performing PDL for PWB. Given potential adverse neurocognitive effects from general anesthesia (GA) exposure in early childhood, we sought to establish current attitudes and practice patterns regarding anesthesia when treating PWB with PDL. METHODS: An electronic REDCap survey was distributed to members of the Pediatric Dermatology Research Alliance (PeDRA) and the Society for Pediatric Dermatology (SPD) via email. Aggregate, anonymized results were reported. RESULTS: Among 47 respondents, the majority (83%) identified as board-certified pediatric dermatologists. When treating children <4 years old, 70% endorsed some use of topical anesthesia. Although 87% reported concerns about long-term side effects on development and school performance affecting their pursuit of GA, 61% reported use of GA for PDL in children <4 years old. All 4 (100%) respondents whose PDL was located in the operating room (OR) setting reported use of GA, compared to 6 of 17 (35%) respondents whose PDL machine was not located in the OR. Providers were more likely to use GA in patients between 1 and 4 years old (70%) compared to those <1 year old (2%). CONCLUSIONS: Diverse practice patterns reiterate the need for a standardized anesthetic approach for PDL in young children and continued research on other factors (ie, location/accessibility of PDL, lesion size) impacting anesthesia choices. Given potential neurodevelopmental risks associated with GA, specific guidance to effectively minimize its use in favor of topical anesthetics should be provided.


Asunto(s)
Láseres de Colorantes , Mancha Vino de Oporto , Anestésicos Locales , Actitud , Niño , Preescolar , Dermatólogos , Humanos , Lactante , Láseres de Colorantes/uso terapéutico , Mancha Vino de Oporto/cirugía , Resultado del Tratamiento , Estados Unidos
5.
Pediatr Dermatol ; 37(6): 1057-1062, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32869385

RESUMEN

BACKGROUND: Infantile hemangiomas (IH) are the most common benign tumor of infancy. Although oral propranolol is currently first-line therapy, optimal dosing for treatment of IH remains debated. We sought to identify hemangioma characteristics associated with poor response to standard dosing (2 mg/kg/d) and to assess the therapeutic benefit of higher dosing. METHODS: Retrospective chart review was conducted of 559 patients with IH seen at Johns Hopkins between 2008 and 2018, of whom 245 (44%) were treated with propranolol. Baseline characteristics were compared between patients who received increased propranolol dosing (≥2.5 mg/kg/d) and those who remained on standard dose (2 mg/kg/d). Changes in the Hemangioma Activity Score (HAS) during the increased dosage period were scored by two trained, blinded pediatric dermatologists. RESULTS: Of 245 patients, 204 (83%) received standard 2 mg/kg/d propranolol dosing while 41 (17%) received a higher dose of ≥2.5 mg/kg/d. The most common location of IH in both groups was the face. In the increased dosage group, 85.4% of IH were of mixed or deep morphology with a mean greatest diameter of 4.6 cm. IH requiring increased dosing received longer courses of propranolol (mean of 389 vs. 282 days, P < .001) and underwent higher rates of excision by plastic surgery (26.8% vs. 5.9%, P < .001). Mean change in HAS over the period with dosage ≥2.5 mg/kg/d was minimal (-0.70; P < .001). CONCLUSIONS: Most recalcitrant IH were located on the face, larger in diameter, and of mixed or deep morphology. Patients had little improvement in HAS score with increased propranolol dosing implemented late in the treatment course with over one-fourth ultimately receiving surgical excision.


Asunto(s)
Hemangioma , Neoplasias Cutáneas , Administración Oral , Antagonistas Adrenérgicos beta/uso terapéutico , Niño , Hemangioma/tratamiento farmacológico , Humanos , Lactante , Propranolol/uso terapéutico , Estudios Retrospectivos , Neoplasias Cutáneas/tratamiento farmacológico , Resultado del Tratamiento
7.
J Clin Diagn Res ; 11(5): ZD09-ZD11, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28658922

RESUMEN

Along with function, aesthetics plays an important role in treating partially or completely edentulous patients. Ageing, trauma, tooth loss and neuromuscular disorders have a high impact on tonicity of facial musculature, elasticity of skin as well as function of muscles. Patients affected with Bell's palsy face functional, aesthetic as well as psychological impairment. Common problems are the partial closure of upper eyelid, sagging of lower eyelid and drooping of angle of mouth leading to facial asymmetry, along with difficulty in eating, drinking and speaking. The key to aesthetic restoration is to support and harmonize the collapsed facial musculature with the help of various prosthodontic treatment approaches. This case report attempts to focus on treating completely edentulous patient affected with Bell's palsy with special prosthesis supporting angle of mouth and lower eyelid using novel technique.

8.
Mol Med Rep ; 6(1): 19-22, 2012 07.
Artículo en Inglés | MEDLINE | ID: mdl-22552728

RESUMEN

Understanding of molecular regulatory pathways presents a novel therapeutic approach for the treatment of head and neck cancer. These specific check points are becoming the targeted therapeutic approach. In this review, we highlight certain major signaling mechanisms, which are involved in the pathophysiology of head and neck cancer. Also, we discuss the current ongoing trials based on the in vitro success of targeted therapies.


Asunto(s)
Carcinoma de Células Escamosas/genética , Neoplasias de Cabeza y Cuello/genética , Carcinoma de Células Escamosas/metabolismo , Inhibidor p16 de la Quinasa Dependiente de Ciclina/genética , Inhibidor p16 de la Quinasa Dependiente de Ciclina/metabolismo , Regulación Neoplásica de la Expresión Génica , Neoplasias de Cabeza y Cuello/metabolismo , Humanos , Investigación/tendencias , Transducción de Señal , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo
9.
Am J Emerg Med ; 30(9): 2096.e3-5, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22424988

RESUMEN

Epiploic appendagitis is a rare, self-limiting inflammation of the epiploic appendices or omental appendices. It presents as abdominal pain often misdiagnosed as appendicitis, cholecystitis, or diverticulitis. Epiploic appendagitis can be treated conservatively with anti-inflammatory and pain medications. It is important to diagnose this etiology of abdominal pain in order to avoid long-term hospital stay and other medical expenses including surgery. In this case report we present a rare case of epiploic appendagitis that presents in a 75 year old female patient.


Asunto(s)
Abdomen Agudo/etiología , Infarto/complicaciones , Grasa Intraabdominal/irrigación sanguínea , Abdomen Agudo/diagnóstico , Abdomen Agudo/diagnóstico por imagen , Anciano , Servicio de Urgencia en Hospital , Femenino , Humanos , Infarto/diagnóstico , Infarto/diagnóstico por imagen , Grasa Intraabdominal/diagnóstico por imagen , Tomografía Computarizada por Rayos X
10.
Am J Emerg Med ; 30(9): 2091.e3-5, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22306387

RESUMEN

Heart disease is one of the leading causes of death in the United States. With the increase in substance abuse, the incidence of acute myocardial infarction (MI) in younger population has been on the rise. Traditionally, cocaine has been blamed for acute MI; however, recently, there have been more incidences of marijuana as an inciting factor. We present a case of marijuana-induced acute MI and discuss the proposed mechanism.


Asunto(s)
Fumar Marihuana/efectos adversos , Infarto del Miocardio/inducido químicamente , Adulto , Dolor en el Pecho/etiología , Trastornos Relacionados con Cocaína/complicaciones , Angiografía Coronaria , Electrocardiografía , Servicio de Urgencia en Hospital , Humanos , Masculino , Infarto del Miocardio/fisiopatología , Inhibidores de Fosfodiesterasa 5/efectos adversos , Piperazinas/efectos adversos , Purinas/efectos adversos , Citrato de Sildenafil , Sulfonas/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA